Association of Ovarian Tumor Epithelium Coexpressing HLA-DR and CA-125 Antigens with Tumor Infiltrating Cytotoxic T Lymphocytes
Open Access
- 1 January 2003
- journal article
- Published by Medical Association of Nippon Medical School in Journal of Nippon Medical School
- Vol. 70 (1) , 40-44
Abstract
Understanding of the relationship between tumor infiltrating cytotoxic T lymphocytes (CD 8+TILs) and tumor cells as well as tumor-associated antigens is important and may reflect the extent of immune response of the patient to the tumor, thus providing a useful clue relevant to the prognosis. The purpose of this study was to determine the relationship between the expression of HLA-DR and CA-125 antigens and the presence of CD 8+TILs with regard to the established clinicopathological factors of ovarian carcinomas using immunohistochemical methods. Thirty-one ovarian carcinomas consisting of 20 serous, 7 mucinous, and 4 clear cell types were examined. Of these, 18 (58%) and 22 (71%) were positive for HLA-DR and CA-125 antigens respectively, and the overall mean number of the CD 8+TILs was 7.2±2.9. A significant association was observed between the mean number of CD8+TILs and tumor grade (P=0.01), disease stage (P=0.003), and patient outcome (P=0.01). The mean number of CD 8+TILs in HLA-DR positive (8.6±2.2) or CA-125 positive (8.4±2.1) tumors was significantly higher than that in HLA-DR negative (5.2±2.5; P=0.0003) or CA-125 negative (4.2±2.2; P=0.00002) tumors. These signifcant levels were further enhanced by one order of magnitude when the mean number of CD 8+TILs in tumors postive for both HLA-DR and CA-125 antigens (9.1±1.7) was compared to that in HLA-DR negative or CA-125 negative tumors. The frequency of cancer-related deaths in HLA-DR and CA-125 positive tumors was significantly lower than in the negative tumors (P=0.01). These data suggest that concurrent expression of HLA-DR and CA-125 antigens may augment the immune response of the patient to the tumor, thus providing a potential clue relevant to the prognosis.Keywords
This publication has 11 references indexed in Scilit:
- Preoperative CA 125 LevelsObstetrics & Gynecology, 2002
- CA 125 regression after two completed cycles of chemotherapy: lack of prediction for long-term survival in patients with advanced ovarian cancerBritish Journal of Cancer, 1999
- HLA‐DR expression is a significant prognostic factor in laryngeal cancerAPMIS, 1999
- Histological Typing of Ovarian Tumours1999
- Combined Expression of HLA-DR Antigen and Proliferating Cell Nuclear Antigen Correlate with Colorectal Cancer PrognosisOncology, 1998
- Cisplatin resistance is associated with reduced interferon-γ-sensitivity and increased HER-2 expression in cultured ovarian carcinoma cellsBritish Journal of Cancer, 1997
- Mucin carbohydrate antigens (T, Tn, and Sialyl-Tn) in human ovarian carcinomas: Relationship with histopathology and prognosisHuman Pathology, 1997
- Strong HLA-DR expression in large bowel carcinomas is associated with good prognosisBritish Journal of Cancer, 1993
- HLA class II restriction repertoire of antigen-specific T cells. I. The main restriction determinants for antigen presentation are associated with HLA-D/DR and not with DP and DQHuman Immunology, 1985
- Histocompatibility 1984Immunology Today, 1984